RICTOR and melanoma: This loss also resulted in hypomethylation of the promoter of miR-196b and a subsequent increase in the expression of miR-196b, which directly targets Rictor (mTORC2 component) to inhibit the activation of mTORC2, which is dire for formation and growth of melanoma.